We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02166164
Previous Study | Return to List | Next Study

Characterization of Secondary Hyperalgesia in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02166164
Recruitment Status : Completed
First Posted : June 18, 2014
Last Update Posted : January 27, 2015
Sponsor:
Collaborators:
Copenhagen Trial Unit, Center for Clinical Intervention Research
University of Copenhagen
Information provided by (Responsible Party):
Morten Sejer Hansen, Rigshospitalet, Denmark

Brief Summary:

In this prospective trial we aim to investigate the intra-individual and inter-individual variance in secondary hyperalgesia following pain elicited by the experimental pain model: Brief Thermal Sensitization.

Furthermore we wish to investigate how precise the psychological tests, Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia.


Condition or disease Intervention/treatment Phase
Experimental Pain in Healthy Males Other: Brief thermal sensitization Other: Long thermal stimulation Other: Heat-pain-detection threshold Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Characterization of Secondary Hyperalgesia in Healthy Volunteers
Study Start Date : June 2014
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015

Arm Intervention/treatment
Experimental: Experiemental pain models
all study participants will be tested with the same experimental pain models: Brief thermal sensitization, Long thermal stimulation, and Heat-pain-detection threshold.
Other: Brief thermal sensitization
A small area of the skin of the study participants are heated to 45 degree celsius for 3 minutes, followed by evaluation of secondary hyperalgesia.
Other Name: Experimental thermal pain model

Other: Long thermal stimulation
A small area of the skin of the study participants are heated to 45 degrees celsius for 1 minute. During the 1 minute period, the study participant will continually report pain on an electronic visual analog scale.
Other Name: Experimental pain model

Other: Heat-pain-detection threshold

The threshold for heat pain are evaluated by heating a small area of the study participants skin. When the study participant feels pain, the temperature (degrees celsius) is registered.

4 threshold measurements per session. Heat pain threshold is defined as the average temperature of the 4 measurements.

Other Name: Experimental pain model




Primary Outcome Measures :
  1. Change in area of secondary hyperalgesia following brief thermal sensitization [ Time Frame: Study day 1, 2, 3, and 4. A minimum of 4 weeks. ]
    To determine the intra- and inter-individual variance, and the inter- and intra-observer variance of the secondary hyperalgesia areas following brief thermal sensitization on 4 separate experimental days with two different observers.


Secondary Outcome Measures :
  1. Score of Pain Catastrophizing Scale [ Time Frame: 7 days ]
    How precise does the score of the Pain Catastrophizing Scale predict the size of the area of secondary hyperalgesia?

  2. Score of Hospital Anxiety and Depression Scale [ Time Frame: 7 days ]
    How precise does the score of the Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia?

  3. Score of Subscales of Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale [ Time Frame: 7 days ]
    How precise do the subscales in the two psychological tests (PCS-rumination, PCS-magnification, PCS-helplessness, and HADS-Anxiety, HADS-Depression) predict the size of the area of secondary hyperalgesia?

  4. Heat-pain-detection threshold registered by degrees celsius [ Time Frame: 1 minute per session ]
    How precise do the Heat-pain-detection threshold evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Heat-pain-detection threshold on 4 separate experimental days with 1 session per experimental day.

  5. Pain following Long Thermal Stimulation, evaluated by maximum on the visual analog scale [ Time Frame: 1 minute per session ]
    How precise does the Max. VAS-score following Long Thermal Stimulation evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Long Thermal Stimulation on 4 separate experimental days with 1 session per experimental day.

  6. Pain following Long Thermal Stimulation, evaluated by Area under the curve of the visual analog scale. [ Time Frame: 1 minute per session ]
    How precise does the VAS-Area Under the Curve following Long Thermal Stimulation evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Long Thermal Stimulation on 4 separate experimental days with 1 session per study day.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age >18 years and <35 years
  • Speak and understand Danish
  • Male gender
  • Test subjects who have understood and signed the informed consent
  • No prescription medicine during the last 30 days

Exclusion Criteria:

  • Test subjects that cannot cooperate to the test
  • Test subjects with an alcohol and/or substance abuse, assessed by the investigator
  • Test subjects, who have consumed one or several types of analgesics 2 <days before the study
  • Test subjects, who have consumed antidepressant medication during the last 30 days before the study
  • Test subjects with chronic pain
  • Test subjects with psychiatric diagnoses
  • Test subjects with tattoos on the extremities
  • Body Mass Index of >30 or <18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02166164


Locations
Layout table for location information
Denmark
Department of anaesthesia and surgery, 4231, Rigshospitalet
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Copenhagen Trial Unit, Center for Clinical Intervention Research
University of Copenhagen
Investigators
Layout table for investigator information
Study Director: Jørgen B Dahl, MD, Doc. Med, Consultant Department of anaesthesiology, dep. Z, Bispebjerg Hospital, Denmark
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Morten Sejer Hansen, MD, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT02166164    
Other Study ID Numbers: SM1-MSH-2014
First Posted: June 18, 2014    Key Record Dates
Last Update Posted: January 27, 2015
Last Verified: January 2015
Keywords provided by Morten Sejer Hansen, Rigshospitalet, Denmark:
Pain
Secondary hyperalgesia
thermal sensitization
Catastrophization
Anxiety
Additional relevant MeSH terms:
Layout table for MeSH terms
Hyperalgesia
Somatosensory Disorders
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases